Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis' Cosentyx Boosted By High Psoriasis Skin Clearance Over 4 Years

Oct 02 2016

• By Sten Stovall

Psoriatic Skin_1200x675

Related Content

Clever Marketing Needed To Position J&J's New Psoriasis Drug Ahead Of Cheaper Options

Oct 01 2016

New Data Bolsters Cosentyx In AS & PsA; Humira Head-To-Head Planned

Jun 08 2016

Related Companies

Novartis AG

Johnson & Johnson

Bristol Myers Squibb Company

AbbVie Inc.

Additional Topics

Research & Development Companies Drug Safety Inflammation BioPharmaceutical

More from R&D

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window